SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                      For Quarter Ended September 30, 1999


                          Commission File Number 1-8635


                          AMERICAN MEDICAL ALERT CORP.
        (Exact Name of Small Business Issuer as Specified in its Charter)


           NEW YORK                                11-2571221
(State or other jurisdiction of         (I.R.S. Employer Identification
 incorporation or organization)                     Number)


                3265 Lawson Boulevard, Oceanside, New York 11572
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (516) 536-5850
                (Issuer's telephone number, including area code)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act of 1934  during the  preceding  12
months (or for such shorter period that the registrant was required to file such
reports),  and (2) has been subject to such filing  requirements for the past 90
days. Yes X No __

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest  practicable  date:  6,377,922 shares of $.01 par
value common stock as of November 12, 1999.


<PAGE>



                          AMERICAN MEDICAL ALERT CORP.
                                      INDEX


                          PART I FINANCIAL INFORMATION


                                                                           PAGE

Item 1.        Financial Statements.


               Condensed Consolidated Balance Sheets for
               September 30, 1999 and December 31, 1998                     3

               Condensed Consolidated Statements of Income for the          4
               Nine Months Ended September 30, 1999 and 1998

               Condensed Consolidated Statements of Income for the          5
               Three Months Ended September 30, 1999 and 1998

               Condensed Consolidated Statements of Cash Flows for          6
               the Nine  Months Ended September 30, 1999 and 1998

               Notes to Condensed Consolidated Financial Statements       7-8

Item 2.        Management's Discussion and Analysis of
               Financial Condition and Results of Operations.             9-12



                            PART II OTHER INFORMATION



Item 3.        Exhibits and Reports on Form 8-K.                            12




<PAGE>



Item 1.  Financial Statements
-----------------------------

<TABLE>
<CAPTION>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                     ASSETS

                                                                                      September 30, 1999         December 31,1998*
                                                                                       (Unaudited)               -----------------
                                                                                      ------------------
        CURRENT ASSETS:

<S>                                                                               <C>                     <C>
           Cash                                                                   $           916,850     $          1,419,842

           Accounts and notes receivable

           (net of allowance for doubtful accounts of $60,000 in '99 & `98))                2,196,366                2,170,498

           Inventory                                                                        2,082,631                1,329,526

           Prepaid expenses and other current assets                                          391,115                  139,632

           Deferred income tax benefit                                                        121,000                  121,000
                                                                                      ---------------           --------------


        TOTAL CURRENT ASSETS                                                      $         5,707,962     $          5,180,498

        FIXED ASSETS:

           (Net of accumulated depreciation and amortization)                               5,179,868                4,541,346

        OTHER ASSETS                                                                          293,115                  202,352
                                                                                      ---------------           --------------


        TOTAL ASSETS                                                              $        11,180,946     $          9,924,196
                                                                                      ---------------           ==============



                                 LIABILITIES AND SHAREHOLDER'S EQUITY

        CURRENT LIABILITIES:

           Accounts payable                                                       $           302,162     $            185,394

           Accrued expenses                                                                   248,010                  142,342

           Taxes payable                                                                        -                       21,569

           Current portion of long-term debt                                                  133,517                   44,110
                                                                                      ---------------           --------------

        TOTAL CURRENT LIABILITIES                                                             683,689                   93,415
                                                                                      ---------------           --------------

        Deferred Income Tax Liability                                                         332,000                  332,000

        Deferred Income                                                                        19,966                   22,766

        Long term debt - less current maturities                                              372,960                  148,542
                                                                                      ---------------           --------------

        TOTAL LIABILITIES                                                         $         1,408,615     $            896,723
                                                                                      ---------------           --------------

        COMMITMENTS AND CONTINGENT LIABILITIES

        SHAREHOLDERS' EQUITY

           Common  stock - $.01  par  value;  authorized  -  10,000,000  shares;
        issued  6,421,832 shares in 1999 and 6,397,570 shares in 1998.            $            64,218     $             63,976

           Additional paid-in capital                                                       6,150,951                6,089,050

           Retained Earnings                                                                 ,663,194                2,980,479
                                                                                      ---------------           --------------

                                                                                            9,878,363                9,133,505

           Less 43,910 shares in 1999 & 1998 of treasury stock, at cost                      (106,032)                (106,032)
                                                                                      ----------------          ---------------


        TOTAL STOCKHOLDERS' EQUITY                                                          9,772,331                9,027,473
                                                                                      ---------------           --------------


       TOTAL LIABILITIES & SHAREHOLDERS' EQUITY                                  $        11,180,946     $          9,924,196
                                                                                      ================           ==============

          See accompanying notes to condensed financial statements.

                      * Derived from audited financial statements


</TABLE>

                                      -3-

<PAGE>




<TABLE>
<CAPTION>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY

                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)




                                                                                         Nine Months Ended September 30,
                                                                                         -------------------------------
                                                                                         1999                       1998
                                                                                         ----                       ----

     Revenues:

<S>                                                                                     <C>                    <C>
              Services                                                                  $ 6,505,990            $5,758,704

              Product Sales                                                                 259,284               422,770
                                                                                           --------               -------

                                                                                          6,765,273             6,181,474
                                                                                          ---------             ---------



     Cost and Expenses (Income):

              Costs related to services                                                   2,408,436             2,063,540

              Costs of products sold                                                        249,130               354,653

              Selling, general and administrative expenses                                2,786,343             2,375,657

              Interest expense                                                               19,283                14,462

              Other expenses                                                                115,000                   -0-

              Other income                                                                                   (7,963)
                                                                                           (16,636)

                                                                                          5,561,557             4,800,349
                                                                                          ---------             ---------



     Income before provision for income taxes                                             1,203,715             1,381,125



     Provision for income taxes                                                             521,000               612,000
                                                                                            -------               -------



     NET INCOME                                                                           $ 682,715              $769,125
                                                                                          ---------              --------

     Net Income per share:

              Basic                                                                         $   .11               $   .13
                                                                                            -------               -------

              Diluted                                                                       $   .11                $  .13
                                                                                            -------                ------



     Weighted average number of common shares outstanding (Note 3)

              Basic                                                                       6,373,708             5,907,409
                                                                                          ---------            ----------

              Diluted                                                                     6,471,171             6,006,736
                                                                                          =========             =========

     See accompanying notes to condensed financial statements
</TABLE>


                                      -4-

<PAGE>





<TABLE>
<CAPTION>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY

                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)

                                                                                   Three months Ended September 30,
                                                                                   --------------------------------

                                                                                         1999                 1998
                                                                                         ----                 ----

             Revenues:

<S>                                                                               <C>                  <C>
                      Services                                                    $ 2,209,199          $ 2,028,487

                      Product Sales                                                   100,392              107,967
                                                                                      -------              -------
                                                                                    2,309,591            2,136,454
             Cost and Expenses (Income):

                      Cost related to service                                         797,876              696,261

                      Costs of products sold                                           97,537              103,906

                      Selling, general and administrative expenses                    950,530              833,419

                      Interest expense                                                  9,382                4,366

                      Other expenses                                                  115,000                  -0-

                      Other Income                                                    (3,377)              (4,363)
                                                                                      -------              -------

                                                                                    1,966,948            1,633,589
                                                                                    ---------            ---------

             Income before provisions for income taxes                                342,643              502,865

             Provision for income taxes                                               150,000              223,000
                                                                                      -------              -------

             NET INCOME                                                             $ 192,643             $279,865
                                                                                    ---------             --------

             NET INCOME PER SHARE

                      Basic                                                           $   .03              $   .05
                                                                                     --------              -------

                      Diluted                                                         $   .03              $   .05
                                                                                     --------              -------

             Weighted average number of common shares outstanding (Note 3)

                      Basic                                                         6,377,922            5,948,419
                                                                                    ---------            =========

                      Diluted                                                       6,391,691            6,098,342
                                                                                    =========            =========



             See accompanying notes to condensed financial statements
</TABLE>


                                      -5-

<PAGE>
<TABLE>
<CAPTION>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY

                 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
                                   (Unaudited)

                                                                                             Nine Months Ended September  30,
                                                                                             --------------------------------

                                                                                              1999                     1998
                                                                                              ----                     ----

 Cash Flows From Operating Activities:

<S>                                                                                      <C>                      <C>
               Net Income                                                                $ 682,715                $ 756,125

               Adjustments to reconcile net income to
               Net cash provided by operating activities

                Provision for bad debts                                                          0                   30,000

                Depreciation and amortization                                              923,790                  734,171

                Loss on unrecovered leased medical equipment                                68,202                   64,200

                Change in Assets and Liabilities:

                 (Increase) Decrease in receivables                                       (25,868)                (228,843)

                 (Increase) Decrease in inventory                                        (753,105)                   39,816

                 (Increase) in prepaid expenses, deferred taxes,
                     and other assets                                                    (258,221)                (212,754)


                 Increase (decrease) in accounts payable, accrued
                     expenses, taxes payable and deferred income                          198,067                  (65,335)
                                                                                          --------                 --------

 Net Cash Provided by Operating Activities                                                835,580                 1,130,380
                                                                                          --------                ---------



 Cash Flows from Investing Activities:

                 Net expenditures for fixed assets                                     (1,605,540)              (1,001,564)

                 Payment for account acquisitions                                              -0-                (191,500)

                 Payment for licensing agreement                                          (65,000)                    -0-

 Net Cash (Used In) Investing Activities                                               (1,670,540)             ( 1,193,064)
                                                                                       -----------             ------------




 Cash Flows from Financing Activities:

                  Repayment of bank borrowing                                                  -0-                (150,000)

                  Increase (Decrease) in loans payable                                      19,825                  234,849

                  Net Proceeds upon exercise of stock options                               62,143                  187,278

                  Sale/leaseback of equipment                                              250,000                      -0-

 Net Cash Provided by Financing Activities                                                 331,968                  272,127
                                                                                           -------                  -------



 Net (Decrease) increase in Cash                                                       $ (502,992)                $ 209,443

 Cash, Beginning of Period                                                               1,419,842                  304,739
                                                                                         ---------                  -------

 Cash, End of Period                                                                  $    916,850                $ 514,182
                                                                                       -----------                =========



 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:



 CASH PAID DURING THE PERIOD
 FOR INTEREST                                                                             $ 19,283                 $ 14,462
                                                                                          --------                 ========



 CASH PAID DURING THE PERIOD
 FOR INCOME TAXES                                                                        $ 631,268                $ 540,809
                                                                                         ---------                =========

</TABLE>
                                      -6-

<PAGE>



                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY
              Notes to Condensed Consolidated Financial Statements
                                   (Unaudited)


1.       General:

         These  financial  statements  should  be read in  conjunction  with the
         financial  statements and notes thereto for the year ended December 31,
         1998 included in the Company's Annual Report on Form 10-KSB.

         In July  1999,  Safe Com,  Inc.  was  incorporated  as a wholly  owned
         subsidiary.   Safe  Com  is  developing   state  of  the  art  passive
         security/interactive voice technologies.


2.       Results of Operations:

         In the opinion of  management,  the  accompanying  unaudited  condensed
         consolidated  financial statements contain all adjustments  (consisting
         only of normal  recurring  accruals)  necessary  to present  fairly the
         financial  position of the Company as of September  30,  1999,  and the
         results  of  operations  and of cash  flows for the nine  months  ended
         September 30, 1999 and 1998.

         The accounting  policies used in preparing these  financial  statements
         are the same as those  described  in the  December  31, 1998  financial
         statements.

         The results of operations for the nine months ended  September 30, 1999
         are not  necessarily  indicative  of the results to be expected for any
         other interim period or for the full year.


3.       Major Customers:

         The Company is an approved  Medicaid Provider in the State of New York.
         During the nine months ended  September 30, 1999 and 1998,  the Company
         had  revenue  from  one  contract  with  the  City  of New  York  which
         represented, respectively, 41% and 43%, respectively, of total revenues
         for each period.  The  contract  with HCSP expired on June 30, 1999 and
         the Company  continues  to service New York City's  Medicaid  Home Care
         Services  Program  (HCSP) under the terms and conditions of the expired
         contract.  In January 1999,  the Company  submitted its proposal to the
         City of New York to renew and extend the contract. On October 22, 1999,
         the  Company  was  advised  by  HCSP  that  another  company  had  been
         preliminarily recommended.  The Company is reviewing HCSP's preliminary
         recommendation  and is  assessing  alternative  options  and courses of
         action.  On November 1, 1999,  the Company  submitted a formal  protest
         pursuant to paragraph 4-04 of the Rules of the Procurement Policy Board
         of the  City of New  York  to  contest  the  preliminary  award.  As of
         November 12, 1999, the contract had not been awarded.


                                      -7-

<PAGE>


         If the City of New York HCSP awards the contract to another vendor,  a
         significant  amount of the Company's  revenues would be lost, having a
         material  adverse  effect on operating  results.  In  addition,  it is
         possible that  significant  future  adjustments to inventory and fixed
         assets associated with the contract could occur.  However, the Company
         cannot  assess  the  full  financial   impact  at  this  time,  as  no
         determination can be made on the duration and manner of the transition
         to another vendor.

         As of September  30, 1999 and December  31, 1998,  accounts  receivable
         from the New York City contract represented 61% and 66%,  respectively,
         of the accounts  receivable and leased medical devices in service under
         the contract represented 40% and 42%,  respectively,  of leased medical
         devices.  Inventory relating to this contract represented approximately
         25% of total  inventory on hand as of  September  30, 1999 and December
         31, 1998.


                                      -8-
<PAGE>






                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY

Item 2.  Management's Discussion and Analysis of Financial Condition and Results
--------------------------------------------------------------------------------
of Operations
-------------

The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the consolidated  financial  statements contained in the latest
Annual Report dated December 31, 1998.

This  discussion  contains  forward-looking  statements  which,  in  addition to
assuming a  continuation  of the degree and timing of customer  utilization  and
rate of renewals of contracts with the Company at historical levels, are subject
to a number of known and unknown  risks that,  in addition to general  economic,
competitive  and  other  business   conditions,   could  cause  actual  results,
performance  and  achievements  to differ  materially  from those  described  or
implied in the forward-looking statements.

Liquidity and Capital Resources
-------------------------------

On April 27,  1998,  the Company  renegotiated  a $ 2,000,000  Revolving  Credit
Facility with a bank (based upon 75% of eligible accounts  receivable and 25% of
inventory,  as defined)  expiring May 31, 2000.  The note bears  interest at the
lower of prime rate or LIBOR Rate plus 2.50% (as defined) and is  collateralized
by the  Company's  assets.  There are no  amounts  outstanding  under the Credit
Facility as of November  12,  1999.  The  agreement  provides  for  negative and
affirmative  covenants  including  those related to tangible net worth,  working
capital and other borrowing.  Prior to April 27, 1998, the Company had a similar
arrangement with another bank which permitted borrowing up to $2,000,000.

During 1999, the Company  anticipates  that it will make capital  investments of
approximately  $2,200,000 of which  approximately  $1,600,000  has been expended
through  September 30, 1999.  Of the  $1,600,000,  $1,300,000  has been expended
through  September,  1999 for the design,  production and purchase of additional
systems which the Company intends to rent. In addition,  approximately  $300,000
has been used primarily for the enhancement of management  information  systems.
In October 1999, the Company  entered into a sale and leaseback  transaction for
such equipment.

The Company  believes that its present cash and working  capital  position,  its
borrowing  availability and future anticipated income will be sufficient to meet
its cash and working capital needs for the foreseeable future.

The Company derives a significant  portion of its revenue from one contract with
the City of New York's Medicaid Home Care Services  Program  (HCSP).  During the
nine months ended September 30, 1999 and 1998, the Company had revenue from this
contract which represented 41% and 43%, respectively, of total revenues for each
period.  Leased medical devices in service relating to this


                                       -9-

<PAGE>

contract represented 40% and 42%, respectively,  of total leased medical devices
at September 30, 1999 and December 31, 1998. Inventory relating to this contract
represented  approximately  25% of total inventory on hand at September 30, 1999
and December 31, 1998.  The contract  with HCSP expired on June 30, 1999 and the
Company continues to service New York City's Medicaid Home Care Services Program
(HCSP) under the terms and  conditions of the contract that expired.  In January
1999,  the Company  submitted  its proposal to the City of New York to renew and
extend the contract.

On October 22, 1999,  the Company was advised by HCSP that  another  company had
been  preliminarily  recommended.  The Company is reviewing  HCSP's  preliminary
recommendation  and is assessing  alternative  options and courses of action. On
November 1, 1999, the Company  submitted a formal protest  pursuant to paragraph
4-04 of the  Rules of the  Procurement  Policy  Board of the City of New York to
contest the  preliminary  award.  As of November 12, 1999,  the contract had not
been awarded.

If the  City  of New  York  HCSP  awards  the  contract  to  another  vendor,  a
significant  amount of the Company's  revenues would be lost,  having a material
adverse  effect  on  operating  results.  In  addition,   it  is  possible  that
significant future adjustments to inventory and fixed assets associated with the
contract  could occur.  However,  the Company  cannot assess the full  financial
impact at this time,  as no  determination  can be made as to the  duration  and
manner of the transition to another vendor.

In the event of such  non-renewal,  the  Company's  management  will continue to
build  its  subscriber  base  through  consumers,  healthcare  agencies,  health
maintenance  organizations,  durable  medical  equipment  providers,  retirement
communities, hospitals and other governmental agencies.



Year 2000 Compliance
--------------------

General

The Company has evaluated its management  information  systems to determine what
modifications,  if any, are necessary to make such systems  compatible with Year
2000  requirements.  As many of the Company's computer systems and software have
been put into service within the last few years, or are currently being replaced
with Year 2000 compliant  systems and software,  the Company does not expect any
such  modifications to require material  expenditures or have a material adverse
effect on the Company's financial position or results of operations. The Company
anticipates that any  modifications  required to be made to its software systems
to comply with the Year 2000 Issue will be completed in a timely manner.

Third Parties

The Company has also initiated formal  communications with significant suppliers
and other key third  parties to  determine  the  extent to which the  Company is
vulnerable  to those  third  parties'  failure  to  resolve  their own Year 2000
compliance issues. There can be no assurance that the systems of other companies
on which the Company's system rely will be timely  converted,  or that a


                                      -10-

<PAGE>



failure to convert by another company, or a conversion that is incompatible with
the Company's systems, would not have a material adverse effect on the Company's
results of operations.


Risk Assessment/Contingency Planning

At this  time,  the  Company  believes  its most  reasonable  likely  worst case
scenario  would  include  (i)  a  key  material   vendor  or  service   provider
experiencing  problems with delivery of  materials,  components or services;  or
(ii) the failure of infrastructure  services provided by government agencies and
other third parties  (e.g.,  electricity,  telephone,  transportation,  Internet
services,  etc.).  As noted  above,  the  Company  is  evaluating  the Year 2000
compliance status of its key third-party vendors to identify potential risks for
contingency  planning  purposes.  The Company  continues to prepare  appropriate
contingency plans as will be determined to be necessary.

Results of Operations
---------------------

Revenue from services (Recurring Monthly Revenues,  or "RMR") increased $747,286
for the nine months ended  September  30, 1999 as compared to the same period in
1998, an increase of 13%. Costs related to service  revenues for the nine months
ended  September 30, 1999 and 1998 were 37% and 36%  respectively.  Revenue from
services  increased $ 180,712 for the three months ended  September  30, 1999 as
compared  to the same  period in 1998,  an  increase  of 9 %.  Costs  related to
service revenues for the three months ended September 30, 1999 and 1998 were 36%
and 34%  respectively.  The  increases in revenue and the growth of RMR resulted
from the Company  refocusing its sales and marketing  efforts towards the growth
of the subscriber base, rental income and service revenues;  however increses in
revenue were offset by increases in personnel and related costs in the Company's
Emergency  Response  Center,  as well as costs related to the Increases in costs
related to service revenues resulted from amortization of leased equipment.  The
Company  believes that future  increases in RMR should be accretive to operating
margins.

Revenue  from  product  sales  decreased  $163,486  for the  nine  months  ended
September  30, 1999 as compared to the same period in 1998,  a decrease of 39 %.
The gross profit on product  sales for the nine months ended  September 30, 1999
and 1998 was 4% and 16 % respectively.  Product sales accounted for 4% and 7% of
total  revenues  for  the  nine  months  ended   September  30,  1999  and  1998
respectively.  Revenue from product sales decreased  $7,575 for the three months
ended September 30, 1999 as compared to the same period in 1998, a decrease of 7
%. The gross profit on product  sales for the three months ended  September  30,
1999 and 1998 was 4% in both periods.  Product sales  accounted for 4% and 5% of
total  revenues  for  the  three  months  ended  September  30,  1999  and  1998
respectively.  Management anticipates that product sales should improve somewhat
through sales generated by its recently introduced Model 450 Smart Activator, an
advanced remote  signalling  devise  featuring built in battery  monitoring that
reduces the costs associated with program maintenance.

Interest  expense for the nine months  ended  September  30, 1999 and 1998 was $
19,283 and $ 14,462  respectively.  Interest  expense for the three months ended
September 30, 1999 and 1998 was $ 9,382 and $ 4,366  respectively.  Increases in
interest expense for the nine and three months ended September 30, 1999 and 1998
resulted from additional capital leases.

Selling,  general and  administrative  expenses as compared as a  percentage  of
total  revenues for the nine months ended  September  30, 1999 and 1998 were 41%
and 38% respectively.  Selling,  general and administrative expenses as compared
as a percentage of total revenues for the three months ended  September 30, 1999
and 1998 were 41% and 39%  respectively.  The increases in


                                      -11-

<PAGE>


selling,  general and administrative expenses resulted from the expansion of the
Company's  infrastructure  and  preplanned  increases  in  sales  and  marketing
expenditures. Management believes that increases in SG&A expenses were necessary
to increase the Company's  market  visibility  and provide a platform for future
growth and profitability.

Other expenses  incurred during the three months and nine months ended September
30, 1999 include $ 115,000 of  developmental  and start up costs associated with
the Company's  subsidiary,  Safe Com, Inc., which is developing state of the art
passive security/interactive technologies.




PART II. - OTHER INFORMATION



Item 3.  Exhibit and Reports on Form 8-K
----------------------------------------

(a) Exhibits:

         27.  Financial Data Schedule

(b) Reports on Form 8-K:

         No reports on Form 8-K were filed.




                                      -12-
<PAGE>





                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly caused this report to be signed on its behalf by the undersigned  there
unto duly authorized.




                          AMERICAN MEDICAL ALERT CORP.




Dated:  November 12, 1999                   By:/s/ Howard M. Siegel
                                               --------------------------
                                                   Howard M. Siegel
                                                   President and Chief
                                                   Operating Officer



                                            By:/s/ Corey M. Aronin
                                               ---------------------------
                                                   Corey M. Aronin
                                                   Chief Financial Officer